Axios

President Trump on Friday called for changes to the childhood vaccination schedule and how the combined measles, mumps and rubella shot is distributed to children.

Why it matters: Health Secretary Robert F. Kennedy Jr.'s advisors recently voted to limit MMRV access, renewing debate over vaccine timing.

For all the sense of angst about the U.S. economy of late, the American consumer continues powering growth forward.

• New data out this morning confirms that trajectory continued through late summer.

Why it matters: All those recession warnings from earlier in the year are looking flat wrong. When consumers keep spending (which they are) and businesses keep investing (which they also are), the economy can't — almost as a matter of arithmetic — fall into a contraction.

There's an art to crafting a balanced "napuccino" — a fun term for taking a quick snooze after drinking coffee.

Why it matters: A precise timing of coffee and sleep can leave you alert, not groggy.

ADHD researchers and clinicians have started a new coalition to lobby for evidence-based policy around the developmental condition as Health Secretary Robert F. Kennedy Jr. casts doubt on ADHD drugs for kids.

Why it matters: The Trump administration's recent report on the health of American children criticizes what it terms overdiagnosis and inappropriate prescribing of ADHD medications.

Driving the news: Mindful Choices for ADHD launched Thursday with funding from a pharmaceutical company.

• "There are important areas where both research and public information have been lacking," said executive director Jakara Eason.
• "We think that our role is to bring forward the data, highlight areas where more research is needed, and to provide clear guidance so that policymakers can make those informed choices."
• That said, the group was not created to push back or align with Kennedy or his "Make America Healthy Again" movement, Eason said.

Where it stands: The group is an outgrowth of a national leadership summit held earlier this year on appropriate use of ADHD treatments aimed at increasing attention span and better controlling emotions and behavior.

• "There was an appetite to do more and educate not only other folks in the community but also policymakers on what ADHD is and isn't, and then all of the treatment options," Eason said.
• A summary report from the summit shared with Axios says attendees recommended policy action around educating providers and the public on ADHD, promoting additional research on medication use and making sure patients have access to appropriate treatments.
• But Mindful Choices for ADHD plans to talk with lawmakers and administration to build a collaborative policy agenda, Eason said.

Tris Pharma, a specialty drugmaker that produces ADHD therapies, provided the initial funding for the group and sits on the organization's steering committee.

• Also represented on the steering committee are the World Federation of ADHD, the National Association of Pediatric Nurse Practitioners, and doctors and coaches that study the condition and work with patients.

The Trump administration is facing conflicting political pressures after Health Secretary Robert F. Kennedy Jr. said the Food and Drug Administration will "study" adding safety restrictions on abortion pills.

Why it matters: New limits like requiring in-person prescribing of the widely used abortion drug mifepristone would severely limit access to abortion in states with bans.

New litmus test for determining where someone lives: Does coconut coffee creamer sound good or gross?

Why it matters: Instacart's data on the most uniquely popular coffee creamers by state tells a story of regional flavor preferences.

Delaying the morning phone scroll — even by just a few minutes — could do wonders for your brain.

The big picture: We know staring at a screen all day isn't healthy. But even if a full digital detox isn't realistic, an offline morning can still go a long way.

President Trump on Tuesday night threatened to start levying 100% tariffs on imported branded drugs made by companies that haven't committed to building new U.S. facilities by Oct. 1.

Why it matters: The move raises the stakes for drug manufacturers already under pressure from the administration to lower U.S. prices.

Infection rates for a drug-resistant "nightmare bacteria" are rising, per a new report from the CDC.

Why it matters: Antibiotic-resistant bacteria and fungi have caused millions of infections and thousands of deaths annually in the United States.

The Food and Drug Administration said it will conduct a "study" of the safety protocol around the widely used abortion drug mifepristone, in a move that could lead to new dispensing restrictions.

Why it matters: New rules around the drug, especially those addressing its widespread availability through telehealth, could severely limit access in states with abortion bans.

States are moving to set more rules about who's eligible for vaccines and who'll pay for them. But that isn't much help to nearly 100 million people with workplace insurance.

Why it matters: Self-insured health plans have to follow federal guidelines, which are in flux as Health Secretary Robert F. Kennedy Jr. and his vaccine advisers debate new limits on COVID-19, hepatitis B and other shots.